Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Good Comments, Engcan.

<< Previous

Bullboard Posts

Next >>

Comment by tylerreddickon Dec 15, 2023 4:06pm

162 Views

Post# 35787420

RE:RE:Good Comments, Engcan.

If there wasn't the years long history of failures to launch, we would likely be in the dollars, not pennies.
That is all on our less than forthright management, and their stupid deals like the Rodan and Fields joke.
But again, no one is here because of the lousy management, we are here because of the science, and it appears to be solid. JMO

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals